Comparison of levels of human immunodeficiency virus type 1 RNA in plasma as measured by the NucliSens nucleic acid sequence-based amplification and Quantiplex branched-DNA assays

Journal of Clinical Microbiology

Volumn 37, Issue 4, 1999, Pages 1210-1212

  Ginocchio, C C ^a,b   Tetali, S ^a   Washburn, D ^a   Zhang, F ^a   Kaplan, M H ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b N Shore LIJ Hlth Syst Labs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ACCURACY; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; SEQUENCE ANALYSIS; VIRUS DETECTION; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032998965     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.4.1210-1212.1999     Document Type: Article

References (26)

1. Alaeus, A., K. Lidman, A. Sonnerberg, and J. Albert. 1997. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS 11:859-865.
2. Bagnarelli, P., S. Menzo, A. Valenza, S. Paolucci, S. Petroni, G. Scalise, R. Sampaolesi, A. Manzin, P. E. Varaldo, and M. Clementi. 1995. Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds. J. Clin. Microbiol. 33:16-23.
3. Coombs, R. W., S. L. Welles, C. Hooper, P. S. Reichelderfer, R. T. D'Aquila, A. J. Japoyr, V. A. Johnson, D. R. Kuritzkes, D. D. Richman, S. Kwok, J. Todd, J. B. Jackson, V. De Gruttola, C. S. Crumpacker, and J. Kahn. 1996. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. J. Infect. Dis. 174:704-712.
4. Coombs, R. W. 1994. HIV-1 burden as a marker of disease progression and clinical response to therapy in AIDS. Clin. Lab. Med. 14:301-311.
5. Coste, J., B. Montes, J. Reynes, M. Peeters, C. Segarra, J. P. Vendrell, E. Delaporte, and M. Segondy. 1996. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Med. Virol. 50:293-302.
6. Cunningham, A. L., D. E. Dwyer, and D. N. Dowton. 1993. Viral markers in HIV infection and AIDS. J. Acquired Immune Defic. Syndr. 6(Suppl. 1): S32-S35.
7. Dyer, J. R., B. L. Gilliam, J. J. Eron, L. Grosso, M. S. Cohen, and S. A. Fiscus. 1996. Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA™ with Amplicor™ reverse transcription-PCR amplification and correlation with quantitative culture. J. Virol. Methods 60:161-170.
8. Griffith, B. P., M. O. Rigsby, R. B. Garner, M. M. Gordon, and T. M. Chacko. 1997. Comparison of the Amplicor HIV-1 Monitor test and the nucleic acid sequence-based amplification assay for quantitation of human immunodeficiency virus RNA in plasma, serum, and plasma subjected to freeze-thaw cycles. J. Clin. Microbiol. 35:3288-3291.
9. Hogervost, E., S. Jurriaans, F. de Wolf, A. van Wijk, A. Wiersma, M. Valk, M. Roos, B. van Gemen, R. Coutinho, F. Miedema, and J. Goudsmit. 1995. Predictors for non and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of HIV-1 p24-specific but not V3-specific antibody levels. J. Infect. Dis. 171:811-821.
10. Holodniy, M., D. A. Katzenstein, D. M. Israelski, and T. C. Merigan. 1991. Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction. J. Clin. Investig. 88:1755-1759.
11. Holodniy, M., D. A. Katzenstein, M. A. Winters, J. Montoya, R. Shafer, M. Kozal, M. Ragni, and T. C. Merigan. 1993. Gene amplification techniques to measure viral load and genotypic resistance in asymptomatic subjects treated with combination therapy. J. Acquired Immune Defic. Syndr. 6:366-369.
12. Katzenstein, T. L., C. Pederson, C. Nielsen, J. D. Lundgren, P. H. Jakobsen, and J. Gerstoft. 1996. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 10: 167-173.
13. Kievits, T., B. van Gemen, D. van Strijp, R. Schukkink, M. Dircks, H. Adriaanse, L. Malek, R. Sooknanan, and P. Lens. 1991. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol. Methods 35:273-286.
14. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo, J. A. Todd, B. S. Hoo, R. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
15. Mellors, J. W., A. Munoz, J. V. Giorgio, J. B. Margolick, C. J. Tassoni, P. Gupta, L. A. Kingsley, J. A. Todd, A. J. Saah, R. Detels, J. P. Phair, and C. Rinaldo, Jr. 1997. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126:946-954.
16. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
17. O'Brien, W. A., P. M. Hartigan, D. Martin, J. Esinhart, A. Hill, S. Benoit, M. Rubin, C. Lahart, N. Wray, et al. 1996. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N. Engl. J. Med. 334:426-431.
18. Pachl, C., J. A. Todd, D. G. Kern, P. J. Sheridan, S. J. Fong, M. Stempien, B. Hoo, D. Besemer, T. Yeghiazarian, B. Irvine, J. Kolberg, R. Kokka, P. Neuwald, and M. S. Urdea. 1995. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J. Acquired Immune Defic. Syndr. 8:446-454.
19. Revets, H., D. Marissens, S. De Wit, P. Lacor, N. Clumeck, S. Lauwers, and G. Zissis. 1996. Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV Monitor, and QUANT1PLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:1058-1064.
20. Saag, M. S., M. Holodniy, D. R. Kuritzkes, W. A. O'Brien, R. Coombs, M. E. Poscher, D. M. Jacobsen, G. M. Shaw, D. D. Richman, and P. A. Volberding. 1996. HIV viral load markers in clinical practice. Nat. Med. 2:625-629.
21. Schooley, R. T. 1995. Correlation between viral load measurements and outcome in clinical trials of antiviral drugs. AIDS 9(Suppl. 2):S15-S19.
22. Schuurman, R., D. Descamps, G. J. Weverling, S. Kaye, J. Tijnagel, I. Williams, R. van Leeuwen, R. Tedder, C. A. Boucher, F. Brun-Vezinet, and C. Loveday. 1996. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:3016-3022.
23. Urdea, M. 1993. Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, HCV, and HIV. Clin. Chem. 39:725-726.
24. Vandamme, A. M., J. C. Schmit, S. Van Dooren, K. Van Laethem, E. Gobbers, W. Kok, P. Goubu, M. Witvrouw, W. Peetermans, E. De Clercq, and J. Desmyter. 1996. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV Monitor test. J. Acquired Immune Defic. Syndr. 13:127-139.
25. van Gemen, B., P. V. D. Wiel, and R. van Beuningen. 1995. The one-tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application. PCR Methods Appl. 4:S177-S184.
26. van Gemen, B., R. van Beuningen, A. Nabbe, D. ran Strijp, S. Jurriaans, P. Lens, and T. Kievits. 1994. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescence (ECL) labeled probes. J. Virol. Methods 49:157-168.